Home Alzheimer’s Disease

Alzheimer’s Disease

Phase II Trial of Bevacizumab/Trebananib Combo Fails to Demonstrate Improvements

In the phase II NRG/RTOG 1122 trial, published in Cancer, the combination of bevacizumab (Avastin) and trebananib was found to be well tolerated; however, it...

Regret from Allogeneic HSCT Found to be Related to Disease Recurrence

In a study published in Cancer, the majority of patients who underwent allogeneic hematopoietic stem cell transplantation (alloHCT) and lived to 100 days did not...

Racial/Ethnic Disparities in Pediatric Patients with Brain Cancer

A population-based analysis, published in Scientific Reports, found that racial and ethnic disparities in childhood central nervous system (CNS) tumor survival seem to have their...

Phase III Study Shows Combination Treatment to be Effective for NSCLC

A phase III randomized clinical trial, published in JAMA Oncology, found that carboplatin-pemetrexed treatment followed by pemetrexed maintenance to be a valid option for first-line...

Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 Inhibitors

Patricia Jakel, RN, MN, AOCN, clinical nurse specialist in the Solid Tumor Program at UCLA Medical Center, Santa Monica, was diagnosed with stage III...

Enrique Soto Perez de Celis, MD, MSc, On Treatment for Older Women with TNBC

Enrique Soto Perez de Celis, MD, MSc, geriatric oncologist and researcher in the department of geriatrics at the Instituto Nacional de Ciencias Médicas y...

Half of NCI Cancer Center Physician Directors Received Industry Payments in 2017

In 2017, about half of physician directors of National Cancer Institute (NCI) cancer centers received industry payments, according to a new research letter published...

Can Menopausal Hormone Therapy Increase the Risk of Breast Cancer?

Menopausal hormone therapy (MHT) was associated with an increased risk of breast cancer, according to data from more than 100,000 women with breast cancer...

What Physicians Should Know About Breast Implant-Associated Anaplastic Large Cell Lymphoma

It is key for oncologists and surgeons to be aware of the symptoms of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and how this...

FDA Accepts BLA for Proposed Biosimilar to Bevacizumab, MYL-1402O

The FDA accepted a biologics license application (BLA) for MYL-1402O, a proposed biosimilar to bevacizumab (Avastin), for review under the 351(k) pathway, according to...

Personalized Blood Test Improves MRD Detection in Patients with Breast Cancer

A study, published in Clinical Cancer Research, found that tracking large numbers of individualized tumor mutations in cell-free DNA (cfDNA) can improve minimal residual disease...

Debu Tripathy, MD, On the Future of Triple Negative Breast Cancer Treatment

Debu Tripathy, MD, breast medical oncologist at The University of Texas MD Anderson Cancer Center, spoke about the latest updates in the triple negative...

Most Read

Third COVID-19 Vaccine Earns Emergency Use Authorization Following Favorable Advisory Committee Meeting

The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...

Abiraterone Acetate, Apalutamide Likeliest to Improve Survival for Patients with Castration-Sensitive Prostate Cancer

In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...

Women of Minority Race/Ethnicity, Lower Socioeconomic Status Experience Lower Digital Breast Tomosynthesis Access

A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...

Michael Szarek, PhD, on the Outcomes of a Q-TWiST Analysis From the Phase 3 TIVO-3 Study

An analysis revealed that as a third- or fourth-line treatment for RCC, tivozanib significantly increased Q-TWiST compared with sorafenib, primarily through an increase in...